Variant report
Variant | nsv609991 |
---|---|
Chromosome Location | chr8:6119926-6131269 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:25)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:25 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr8:6125905-6126127 | GM12878 | blood: | n/a | n/a |
2 | CEBPB | chr8:6128430-6128600 | HepG2 | liver: | n/a | n/a |
3 | CEBPB | chr8:6128437-6128476 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr8:6128333-6128520 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | CTCF | chr8:6126841-6126881 | GM13976 | blood: | n/a | n/a |
6 | CTCF | chr8:6128364-6128443 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | FOXP2 | chr8:6119300-6119929 | SK-N-MC | brain: | n/a | n/a |
8 | MAFF | chr8:6130086-6130388 | K562 | blood: | n/a | chr8:6130207-6130225 |
9 | MAFF | chr8:6130009-6130401 | HepG2 | liver: | n/a | chr8:6130207-6130225 |
10 | MAFK | chr8:6130046-6130392 | HepG2 | liver: | n/a | chr8:6130209-6130220 chr8:6130209-6130224 chr8:6130209-6130225 chr8:6130210-6130221 chr8:6130208-6130222 chr8:6130209-6130220 |
11 | MAFK | chr8:6130038-6130392 | IMR90 | lung: | n/a | chr8:6130209-6130220 chr8:6130209-6130224 chr8:6130209-6130225 chr8:6130210-6130221 chr8:6130208-6130222 chr8:6130209-6130220 |
12 | MAFK | chr8:6130049-6130397 | HepG2 | liver: | n/a | chr8:6130209-6130220 chr8:6130209-6130224 chr8:6130209-6130225 chr8:6130210-6130221 chr8:6130208-6130222 chr8:6130209-6130220 |
13 | MYC | chr8:6129378-6129403 | H1-hESC | embryonic stem cell: | n/a | n/a |
14 | NFYA | chr8:6125626-6125690 | GM12878 | blood: | n/a | n/a |
15 | POLR2A | chr8:6129147-6129330 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | POLR2A | chr8:6119093-6120785 | SK-N-MC | brain: | n/a | n/a |
17 | POLR2A | chr8:6124909-6124994 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | POLR2A | chr8:6123150-6123690 | SK-N-MC | brain: | n/a | n/a |
19 | POLR2A | chr8:6120188-6120277 | GM12878 | blood: | n/a | n/a |
20 | POLR2A | chr8:6113437-6121012 | SK-N-MC | brain: | n/a | n/a |
21 | RUNX3 | chr8:6125861-6126227 | GM12878 | blood: | n/a | chr8:6126049-6126058 chr8:6126049-6126058 |
22 | RUNX3 | chr8:6125864-6126254 | GM12878 | blood: | n/a | chr8:6126049-6126058 chr8:6126049-6126058 |
23 | SETDB1 | chr8:6125725-6125985 | U2OS | brain: | n/a | n/a |
24 | STAT3 | chr8:6120408-6120534 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | STAT3 | chr8:6120779-6120789 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000253880 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17381669 | chr8:6119926-6119927 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs572244846 | chr8:6119937-6119938 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs546219121 | chr8:6119945-6119946 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs563002328 | chr8:6119946-6119947 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs73192607 | chr8:6119973-6119974 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs548517107 | chr8:6119992-6119993 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs544558477 | chr8:6119995-6119996 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs562273136 | chr8:6120077-6120078 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs34265833 | chr8:6120078-6120079 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371088131 | chr8:6120084-6120085 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs17381683 | chr8:6120093-6120094 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs574456965 | chr8:6120109-6120110 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs570805534 | chr8:6120121-6120122 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs115806479 | chr8:6120139-6120140 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs551739652 | chr8:6120148-6120149 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs543455109 | chr8:6120156-6120157 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs73504040 | chr8:6120190-6120191 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs367900585 | chr8:6120197-6120198 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs192948159 | chr8:6120209-6120210 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs543373328 | chr8:6120211-6120212 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs368597243 | chr8:6120212-6120213 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs574536556 | chr8:6120226-6120227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs533850386 | chr8:6120238-6120239 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs554158561 | chr8:6120244-6120245 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs577191392 | chr8:6120284-6120285 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs184829920 | chr8:6120285-6120286 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs556567261 | chr8:6120297-6120298 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs552875634 | chr8:6120301-6120302 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs17466189 | chr8:6120307-6120308 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs528691243 | chr8:6120319-6120320 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs562144978 | chr8:6120325-6120326 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548367961 | chr8:6120365-6120366 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs527932398 | chr8:6120382-6120383 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs189601410 | chr8:6120398-6120399 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs564475054 | chr8:6120401-6120402 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs149724650 | chr8:6120402-6120403 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73504043 | chr8:6120426-6120427 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs145487210 | chr8:6120431-6120432 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs537183918 | chr8:6120433-6120434 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs531317836 | chr8:6120436-6120437 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs548222969 | chr8:6120437-6120438 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568062719 | chr8:6120441-6120442 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534037330 | chr8:6120487-6120488 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs148852290 | chr8:6120498-6120499 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs73504044 | chr8:6120499-6120500 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs146422488 | chr8:6120513-6120514 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576601283 | chr8:6120539-6120540 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs556605453 | chr8:6120552-6120553 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73504045 | chr8:6120599-6120600 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs375367917 | chr8:6120646-6120647 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:6119400-6120000 | Enhancers | Brain Germinal Matrix | brain |
2 | chr8:6119400-6120000 | Enhancers | Osteobl | bone |
3 | chr8:6119400-6120200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
4 | chr8:6120000-6121000 | Weak transcription | Brain Germinal Matrix | brain |
5 | chr8:6120200-6120800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr8:6120800-6121200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr8:6121000-6121200 | Enhancers | Brain Germinal Matrix | brain |
8 | chr8:6122200-6123200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
9 | chr8:6128200-6128600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |